Opthalmology Times, Digital Edition, February 1st, 2011

Related Videos
Related Content

BNS Ophthalmics created to leverage nanotechnology in the development of ophthalmic pharmaceutical products.

June 9th 2023

Podcast: Wet AMD and the treatment burden on patients

May 3rd 2023

Bausch + Lomb launches Infuse Multifocal SiHy daily disposable contact lenses in the US

June 9th 2023

Podcast: AI/MR in ophthalmology: The future is now

April 7th 2023

Texas ophthalmologist’s license suspended after domestic violence arrest

June 8th 2023

OKYO Pharma announces dosing of first patient in randomized portion of phase 2 trial of OK-101

June 8th 2023

BNS Ophthalmics created to leverage nanotechnology in the development of ophthalmic pharmaceutical products.

June 9th 2023

Podcast: Wet AMD and the treatment burden on patients

May 3rd 2023

Bausch + Lomb launches Infuse Multifocal SiHy daily disposable contact lenses in the US

June 9th 2023

Podcast: AI/MR in ophthalmology: The future is now

April 7th 2023

Texas ophthalmologist’s license suspended after domestic violence arrest

June 8th 2023

OKYO Pharma announces dosing of first patient in randomized portion of phase 2 trial of OK-101

June 8th 2023

BNS Ophthalmics created to leverage nanotechnology in the development of ophthalmic pharmaceutical products.

June 9th 2023

Podcast: Wet AMD and the treatment burden on patients

May 3rd 2023

Bausch + Lomb launches Infuse Multifocal SiHy daily disposable contact lenses in the US

June 9th 2023

Podcast: AI/MR in ophthalmology: The future is now

April 7th 2023

Texas ophthalmologist’s license suspended after domestic violence arrest

June 8th 2023

OKYO Pharma announces dosing of first patient in randomized portion of phase 2 trial of OK-101

June 8th 2023
© 2023 MJH Life Sciences

All rights reserved.